Search

Your search keyword '"Martens U"' showing total 411 results

Search Constraints

Start Over You searched for: Author "Martens U" Remove constraint Author: "Martens U"
411 results on '"Martens U"'

Search Results

1. Broadband spintronic detection of the absolute field strength of terahertz electromagnetic pulses

2. Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial

4. Driving magnetization dynamics in an on-demand magnonic crystal by magneto-elastic interaction

5. Terahertz spin currents and inverse spin Hall effect in thin-film heterostructures containing complex magnetic compounds

6. Efficient metallic spintronic emitters of ultrabroadband terahertz radiation

9. Überleben von Patienten mit metastasiertem Nierenzellkarzinom in der Immuntherapie-Ära: Erste Analysen aus der deutschen Registerplattform CARAT

10. Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

13. Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

18. Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

23. Structure of human MTHFD2 in complex with TH7299

24. Structure of human MTHFD2 in complex with TH9619

27. Correction:High-risk additional chromosomal abnormalities at low blast counts herald death by CML (Leukemia, (2020), 34, 8, (2074-2086), 10.1038/s41375-020-0826-9)

30. Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

32. O-6 EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients (pts) with resected gastroesophageal adenocarcinoma (GEA) following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)—an open-label randomized controlled phase II study

33. O-5 Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG

38. Tumeurs solides

39. Pharmacologie et pharmacothérapie

40. Procédures thérapeutiques particulières

41. Principes de l’ oncologie médicale

42. Diagnostics particuliers

47. Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study

Catalog

Books, media, physical & digital resources